Journals / Türk Nefroloji Diyaliz ve Transplantasyon Dergisi / 2017 / Cilt: 26 - Sayı: 1

Association Between New Cardiac Biomarkers and Cardiovascular Abnormalities in Asymptomatic Hemodialysis Patients

Asemptomatik Hemodiyaliz Hastalarında Kardiyovasküler Biyobelirteçler ve Kardiyovasküler Anormallikler Arasındaki İlişki

Pages
60–66
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

NT-proBNP was negatively correlated with C-reactive protein (r=-41, p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:OBJECTIVE: Cardiovascular diseases are prevalent in asymptomatic chronic hemodialysis patients.
📊
Key Findings & Data:MATERIAL and METHODS: A total of 60 hemodialysis patients who were asymptomatic for cardiovascular diseases and 62 age- and sex-matched healthy subjects were enrolled.
💡
Conclusion & Impact:NT-proBNP was negatively correlated with C-reactive protein (r=-41, p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

OBJECTIVE: Cardiovascular diseases are prevalent in asymptomatic chronic hemodialysis patients. New cardiac biomarkers are required for early diagnosis of cardiovascular diseases. In our study, we aimed to investigate associations of troponin-T (Tn-T), heart type fatty acid binding protein (H-FABP) and N-terminal pro-brain natriuretic peptide (NT-proBNP) levels with clinical, echocardiographic and laboratory parameters of asymptomatic hemodialysis patients. MATERIAL and METHODS: A total of 60 hemodialysis patients who were asymptomatic for cardiovascular diseases and 62 age- and sex-matched healthy subjects were enrolled. Demographic features were recorded, and Tn-T, H-FABP, and NT-proBNP were measured. Clinical, biochemical and echocardiographic evaluations were performed.RESULTS: Tn-T, H-FABP, NT-proBNP levels were significantly higher in hemodialysis patients (p0.05). However, NT-proBNP level >12914 pg/mL was associated with left ventricular hypertrophy. H-FABP was higher in the presence of pulmonary hypertension and tricuspid regurgitation (p=0.025). NT-proBNP was negatively correlated with C-reactive protein (r=-41, p

Özet

AMAÇ: Asemptomatik kronik hemodiyaliz hastalarında kardiyovasküler hastalıklar sık izlemektedir. Kardiyovasküler hastalıkların tanısı için yeni kardiyak biyomarkerlere ihtiyaç vardır. Çalışmamızda, asemptomatik hemodiyaliz hastalarında troponin-T (Tn-T), kalp tipi yağ asit bağlayıcı protein (H-FABP) ve N-terminal pro-brain natriuretik peptid (NT-proBNP) ile klinik, ekokardiyografik ve laboratuvar parametreleri ile ilişkileri araştırıldı. GEREÇ ve yÖNTEMLER: Kardiyovasküler hastalıklar için asemptomatik olan toplam 60 hemodiyaliz hastası ve yaş ve cinsiyet açısından benzer 62 sağlıklı kontrol grubu çalışmaya alındı. Demografik özellikler kaydedildi ve Tn-T, H-FABP ve NT-proBNP ölçüldü. Klinik, biyokimyasal ve ekokardiyografik değerlendirme yapıldı. BULGULAR: Tn-T, H-FABP, NT-proBNP düzeyleri hemodiyaliz hastalarında belirgin olarak daha yüksekti. Kardiyak biyomarkerler ve sol ventikül hipertrofisi veya ejeksiyon fraksiyonu arasında ilişki saptanmadı (p>0.05). Ancak, >12914 pg/ml üzerindeki NT-proBNP düzeyi ile sol ventrikül hipertrofisi ilişkili bulundu. H-FABP, pulmoner hipertansiyon ve triküspit yetmezliğinde daha yüksekti (p=0.025). NT-proBNP, C reaktif protein (r=-41, p

🔖

Cite This Article

TURGUTALP, K., KANIK, A., ÖZCAN, T., KIYKIM, A., DEMİR, S., SARI, S., BARDAK, S., HOROZ, M., OĞUZ, E. G. G. (2022). Association Between New Cardiac Biomarkers and Cardiovascular Abnormalities in Asymptomatic Hemodialysis Patients. Türk Nefroloji Diyaliz ve Transplantasyon Dergisi, Cilt: 26 - Sayı: 1, 60–66. https://ajindex.com/articles/636094

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Roberts MA, Hare DL, Ratnaike S, Ierino FL: Cardiovascular biomarkers in CKD: Pathophysiology and implications for clinical management of cardiac disease. Am J Kidney Dis 2006
  2. 360 2. Hickman PE: Biomarkers and cardiac disease in patients with endstage renal disease on dialysis. Clin Biochem Rev 2011
  3. 119 3. Coll B, Betriu A, Martínez-Alonso M, Borràs M, Craver L, Amoedo ML, Marco MP, Sarró F, Junyent M, Valdivielso JM, Fernández E: Cardiovascular risk factors underestimate atherosclerotic burden in chronic kidney disease: Usefulness of non-invasive tests in cardiovascular assessment. Nephrol Dial Transplant 2010
  4. 3025 4. Hojs R, Bevc S, Ekart R: Biomarkers in hemodialysis patients. Adv Clin Chem 2012
  5. 56 5. Hickman PE, McGill DA, Talaulikar G, Hiremagalur B, Bromley J, Rahman A, Koerbin G, Southcott E, Potter JM: Prognostic efficacy of cardiac biomarkers for mortality in dialysis patients. Intern Med J 2009
  6. 818 6. Satyan S, Light RP, Agarwal R: Relationships of N-terminal pro-Bnatriuretic peptide and cardiac troponin T to left ventricular mass and function and mortality in asymptomatic hemodialysis patients. Am J Kidney Dis 2007
  7. 1019 7. Helal I, Belhadj R, Mohseni A, Bazdeh L, Drissa H, Elyounsi F, Abdallah TB, Abdelmoula J, Kheder A: Clinical significance of N-terminal Pro-B-type natriuretic peptide (NT-proBNP) in hemodialysis patients. Saudi J Kidney Dis Transpl 2010
  8. 268 8. Colbert G, Jain N, de Lemos JA, Hedayati SS: Utility of traditional circulating and imaging-based cardiac biomarkers in patients with predialysis CKD. Clin J Am Soc Nephrol 2015
  9. 529 9. Locatelli F, Hannedouche T, Martin-Malo A, Jacobson SH, Vanholder R, Ronco C, La Milia V, Lopez Gomez JM, Stefoni S, Maheut H, Klinger M, Krummel T, Dhondt A, Berdud I, Gauly A: The relationship of NT-proBNP and dialysis parameters with outcome of incident haemodialysis patients: Results from the membrane permeability outcome study. Blood Purif 2013
  10. 222 10. Tsukahara R, Haniu H, Matsuda Y, Tsukahara T: Heart-type fattyacid-binding protein (FABP3) is a lysophosphatidic acid-binding protein in human coronary artery endothelial cells. FEBS Open Bio 2014
  11. 951 11. TnT Human. [Cited: 20.08.2016]. Access: http://www.prospecbio. com/Troponin-T_Human_10_79/ 12. Khan NA, Hemmelgarn BR, Tonelli M, Thompson CR, Levin A: Prognostic value of troponin T and I among asymptomatic patients with end-stage renal disease: A meta-analysis. Circ